AzTrials
AzTrials

HealthyPROFILENCT04864028

Energy Profile and Low Intensity Activity (PROFILE)

A study testing physical activity in people with Healthy, run by University Hospital, Clermont-Ferrand at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The recent literature has highlighting the importance of the time of SB and the level of physical activity (PA) as predictors of metabolic cardio risks. Now, sedentary lifestyles are well recognized as one of the causes of mortality. Read more about this study

Who is it for?
Ages 20 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
physical activity
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteFrance
Study dates
25 May 2021to 29 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy volunteer, male or female, between 18 and 61 years old
  • Body mass index > 18,5 kg/m2 and ≤ 25 kg/m2
  • Able to provide informed consent to research participation
  • Registered in the French social security system

Who cannot join

  • Subject using a sit-to-stand office desk or a swiss ball
  • Contact jobs (face-to-face with people)
  • Pregnant or breastfeeding women
  • Medical or surgical history determined by principal investigator to be not compatible with the study
  • Subject with cardiorespiratory and/or osteo-articular disorders limiting their ability to perform physical tests or the use of active offices
  • Subject with type 1 or type 2 diabetes treated with insulin
Show all 10Show fewer
  • Subject with progressive cardiovascular or neoplastic disease.
  • Subject with a major infection within 3 months of inclusion.
  • Subject with known neuromuscular pathology: myopathy, myasthenia, rhabdomyolysis, paraplegia, hemiplegia
  • Subject with chronic or acute inflammatory pathology 3 months prior to inclusion

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de Clermont-Ferrand

    Clermont-Ferrand, 63000

Other trials in France

About this study

Official title: Energy Adaptations During Active Workstation Use: Strategy for Individualization of Active Desk Programs

The recent literature has highlighting the importance of the time of SB and the level of physical activity (PA) as predictors of metabolic cardio risks. Now, sedentary lifestyles are well recognized as one of the causes of mortality. As with physical activity, a dose-response relationship appears to exist: mortality would increase with time spent in sedentary behaviors. However, this relationship would not be linear: the more the daily sitting time increases, the more the consequences on mortality are important. It is now well demonstrated that time spent in sedentary adult behaviour finds primarily its origin in the work, characterized by prolonged and uninterrupted periods of sitting. Many strategies have been settled to break the prolonged sitting time. The most promising one seem to be the use of active workstations (standing, walking, cycling, stepping) because they reduce sedentary time at work and increase physical activity with positive effects on the global health. However inter variability in energy response have been identified during a sit to stand allocation with subject "savers" profile showing an increase in energy expenditure while others categorized as "non-savers" increased significantly their energy expenditure between sitting and standing position. As others active workstation strategies exist, this study aim to first, better characterize energy response to posture and activity allocation (15min sit-15min stand-15min sit-15min low intensity cycling), secondly to identify parameters that could explain different energy profile.

Read the detailed description

Subject will have an inclusion visit during a medical consultation where the eligibility criteria to participate to this study will be checked.

During a second experimental visit, subjects will have to take a calibrated breakfast. Three hours after the breakfast, body composition will be assessed and energy expenditure and substrates oxidation will be measured with an indirect calorimetry device during 15min in a sitting position fallowed by 15min in standing position , 15min in a sitting position and 15min of low intensity cycling with a cycling desk.

Then subjects will underwent physical capacity test :

  • 6min step test
  • Handgrip test
  • lower limb strength test Finally, subjects will be equipped with accelerometer and inclinometer device they will need to wore during 7 days.
Conditions
Healthy
Being tested
physical activity
Keywords
Active workstation, cycling, energy expenditure, sedentary
Medical subject headings
Sedentary Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • physical activityOther

    15min sitting, 15min standing, 15min sitting, 15 min low intensity cycling

Study groups in NCT04864028
Study groupRoleWhat they receive
Healthy volunteerExperimentalNot described
Receives: Other: physical activity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. energy expenditure

    Using an indirect calorimetry device change in energy expenditure will be assed during the 1h posture /activity allocation (15min sitting, 15min standing, 15min sitting, 15 min low intensity cycling)

    Measured: change from baseline to the experimental visit (Day 1)

Secondary outcomes (8)
  1. physical activity level (ActiGraph)

    using acceleometry device (ActiGraph Gt3x)

    Measured: during the 7 days following the experimental session

  2. physical activity level (ActivPAL)

    using accelerometry (ActivPAL)

    Measured: during the 7 days following the experimental session

  3. Body composition : fat mass and fat free mass

    body composition will be assessed by bioelectrical impedance device (TANITA MC-780MA)

    Measured: day 0

  4. upper limb strength

    will be assessed with handgrip for upper limb muscle

    Measured: during the experimental session after energy expenditure assessment (Day 1)

  5. aerobic fitness

    will be assessed with the Step Test 6 minutes

    Measured: during the experimental session after energy expenditure assessment (day 1)

  6. lower limb strength

    will be assessed with isokinetic dynamometer

    Measured: during the experimental session after energy expenditure assessment (day1)

  7. eating profile with DEBQ questionnaire (Dutch Eating Behavior Questionnaire)

    the questionnaire will identify with a scale (items to rank between never and always) three major factors influencing eating behavior "emotional , restrained and external eating". For all items score goes from 0 to 5pts and the lower score the better/healthier.

    Measured: during the experimental session before energy expenditure assessment (day 1)

  8. eating profile with TFEQ questionnaire (Three-Factor Eating Questionnaire)

    the questionnaire will identify with a scale (items to rank between never and always) three major eating profiles (cognitive restraint, disinhibition, hunger). For Items 1 to 16 score goes from 4 to 1pts, from items 17-21 score goes from 1 to 4 pts. Global score is calculated the lower the healthier.

    Measured: during the experimental session before energy expenditure assessment (day 1)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Apr 2021
  2. Study start25 May 2021
  3. Primary completion12 Dec 2022
  4. Study completion29 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04864028
Sponsor's protocol ID
RBHP 2020 DUCLOS 3
Other IDs
2020-A03311-38
Acronym
PROFILE
Status last verified
Jul 2023
First submitted
9 Apr 2021
Last updated
10 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing physical activity in people with Healthy, run by University Hospital, Clermont-Ferrand at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

energy expenditure (time frame: change from baseline to the experimental visit (Day 1)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2023; AzTrials last refreshed its copy on 4 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in